The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery

@article{Sorace2005TheMO,
  title={The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery},
  author={R. Sorace and Caroline S. Bagley and Allen S. Lichter and D. Danforth and M. Wesley and Robert C. Young and Marc E. Lippman},
  journal={World Journal of Surgery},
  year={2005},
  volume={9},
  pages={775-785}
}
  • R. Sorace, Caroline S. Bagley, +4 authors Marc E. Lippman
  • Published 2005
  • Medicine
  • World Journal of Surgery
  • Forty-three patients with locally advanced breast cancer, 15 with stage IIIA and 28 with stage IIIB, received primary induction chemotherapy, including hormonal synchronization in 38 patients, to a maximum objective clinical response before proceeding to local therapy. Patients achieving a pathological complete response received radiation therapy, while patients with residual disease, partial response (PR), or no change (NC) status received debulking surgery prior to radiation therapy; in all… CONTINUE READING
    18 Citations
    Approach of Locally Advanced Nonmetastatic Breast Cancer Neoadjuvant Chemotherapy in the Combined Modality
    • PDF
    NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN ADVANCED DISEASE–WHAT ARE THE EFFECTS ON SURVIVAL AND PROGNOSIS?
    • 43
    Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
    • 1,289
    • PDF
    Neoadjuvant chemotherapy for operable breast cancer: is this the future?
    • 19

    References

    SHOWING 1-10 OF 35 REFERENCES
    Multimodal treatment of locoregionally advanced breast cancer
    • 228
    Combined chemotherapy and radiotherapy for locally advanced breast cancer.
    • 92
    Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer
    • 151
    A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization.
    • 96
    • Highly Influential
    A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer
    • 8
    Inflammatory breast carcinoma treated by radical radiotherapy
    • 87